Home sodium monitoring in patients with diabetes insipidus

Rebecca P Green1, Michael Landt

  • 1Department of Pediatrics, Divisions of Endocrinology and Metabolism and Laboratory Medicine, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Missouri, USA.

The Journal of Pediatrics
|November 1, 2002
PubMed

Insights

Home caregivers can accurately measure plasma sodium in children with diabetes insipidus (DI) using a portable clinical analyzer (PCA). This enables reliable home monitoring and treatment decisions for improved fluid management.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Diagnostics
  • Home Healthcare Technology

Background:

  • Diabetes insipidus (DI) requires careful fluid and electrolyte monitoring.
  • Accurate plasma sodium measurement is crucial for managing DI.
  • Home-based monitoring can empower caregivers and improve patient outcomes.

Purpose of the Study:

  • To evaluate the accuracy of home caregivers measuring plasma sodium in children with DI using an I-STAT portable clinical analyzer (PCA).
  • To gather preliminary data on the feasibility and reliability of home PCA use.
  • To assess the impact of home PCA monitoring on clinical outcomes.

Main Methods:

  • Caregivers of 4 children with DI were trained on PCA use.
  • Preclinical phase: PCA sodium measurements by caregivers were compared to laboratory results.
  • Randomized crossover design: Participants alternated between daily home PCA monitoring and routine care.

Main Results:

  • All caregivers successfully performed PCA testing after one training session.
  • Strong correlation between PCA and laboratory sodium measurements (r = 0.92).
  • PCA sodium values would have led to identical treatment decisions in 62 of 66 instances; no significant difference in clinical outcomes was observed between monitoring groups.

Conclusions:

  • Home caregiver use of the portable clinical analyzer provides sufficiently reliable plasma sodium results.
  • PCA measurements support accurate assessment of fluid status and informed treatment decisions in children with DI.
  • Home-based monitoring with PCA is a viable option for managing diabetes insipidus.
Abstract

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...